LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC)

CUSIP: 503459604

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COM PAR $.0001 2
Total 13F shares
18,361,700
Share change
-2,420,513
Total reported value
$78,585,321
Put/Call ratio
118%
Price per share
$4.28
Number of holders
59
Value change
-$10,292,851
Number of buys
19
Number of sells
52

Quarterly Holders Quick Answers

What is CUSIP 503459604?
CUSIP 503459604 identifies LJPC - LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) as of Q2 2021

As of 30 Jun 2021, LA JOLLA PHARMACEUTICAL CO - COM PAR $.0001 2 (LJPC) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,361,700 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, RTW INVESTMENTS, LP, BOXER CAPITAL, LLC, VANGUARD GROUP INC, D. E. Shaw & Co., Inc., MILLENNIUM MANAGEMENT LLC, BlackRock Inc., ACADIAN ASSET MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and MORGAN STANLEY. This page lists 59 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.